Pharmaceutical Literacy and Quality of Life in Spanish Population.

NCT06729697 | Enrolling By Invitation

• 1 other identifier: CER052416
• Study Type: observational
• Target: 1,246
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to learn about the knowledge and abilities that patients have regarding their own medication and to see if that's related to their quality of life. The main questions it aims to answer are:

• Are patients abilities and knowledge about their medications sufficient to ensure a safe and efective use?
• Are those knowledge and abilities related to the patient's quality of life? How? Patients already taking at least one medication will answer questions about their abilities and knowledge towards medication and their quality of life related to their health state.

Conditions

Health Related Quality of Life; Literacy

Keywords

Pharmaceutical literacy; Health related quality of life; Spain; Community pharmacist

Outcome Measures

Primary Outcomes (2)

• Recognising and Addressing Limited Pharmaceutical Literacy (RALPH) interview guide score

  A quantitative score will be obtained after an interview using the RALPH guide for community pharmacy. Only correct answered questions will add a point to the score. The values obtained stand between 0 and 10, and a higher score means a better outcome.

  Through study completion, an average of 1 year.

• EQ-5D-5L index score

  A health state index score will be calculated from individual health profiles using the Spanish value set (Roudijk B, Ludwig K, Devlin N, Roudijk B, Ludwig K, Devlin N. EQ-5D-5L Value Set Summaries. Value Sets for EQ-5D-5L. 2022;55-212.) where the values stand between -0.166 and 1, and a higher score means a better outcome.

  Through study completion, an average of 1 year.

Secondary Outcomes (8)

• Sex

  Through study completion, an average of 1 year.

• Age

  Through study completion, an average of 1 year.

• Country of birth

  Through study completion, an average of 1 year.

• Level of education

  Through study completion, an average of 1 year.

• Situation related to economic activity

  Through study completion, an average of 1 year.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults taking at least one medication in Spain at the moment of the study.

You may qualify if:

• Adults currently taking at least one medication prescribed by a physician and living in Spain.

You may not qualify if:

• Having physical or cognitive limitations that make it impossible to answer the study questions.

Sponsors & Collaborators

• University of Barcelona: lead
• Sociedad Espanola de Farmacia Clinica, Familiar y Comunitaria: collaborator

Study Sites (1)

Clinical Pharmacy and Pharmaceutical Care Unit.

Barcelona, Barcelona, 08028, Spain

Location

Related Publications (2)

• Roudijk B, Ludwig K, Devlin N. EQ-5D-5L Value Set Summaries. 2022 Mar 24. In: Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. Chapter 4. Available from http://www.ncbi.nlm.nih.gov/books/NBK589305/

  PMID: 36810042 BACKGROUND

• Andreu-March M, Aguas Compaired M, Marino EL, Modamio P. Cross-cultural adaptation and validation of the Recognizing And Addressing Limited Pharmaceutical Literacy (RALPH) interview guide in community pharmacies. Res Social Adm Pharm. 2023 Jun;19(6):882-888. doi: 10.1016/j.sapharm.2023.02.004. Epub 2023 Feb 16.

  PMID: 36868912 BACKGROUND

MeSH Terms

Conditions

Literacy

Condition Hierarchy (Ancestors)

Communication; Behavior

Study Officials

• Pilar Modamio Charles, PhD

  University of Barcelona

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Full Professor

Study Record Dates

• First Submitted: November 21, 2024
• First Posted: December 11, 2024
• Study Start: November 15, 2024
• Primary Completion: June 30, 2025
• Study Completion: July 30, 2025
• Last Updated: April 13, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)